CHIKV VLP vaccine booster + Placebo booster
Phase 3Active 0 watching 0 views this week📈 Rising
74
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Chikungunya Virus Infection
Conditions
Chikungunya Virus Infection
Trial Timeline
Aug 30, 2023 → Aug 1, 2028
NCT ID
NCT06007183About CHIKV VLP vaccine booster + Placebo booster
CHIKV VLP vaccine booster + Placebo booster is a phase 3 stage product being developed by Bavarian Nordic for Chikungunya Virus Infection. The current trial status is active. This product is registered under clinical trial identifier NCT06007183. Target conditions include Chikungunya Virus Infection.
Hype Score Breakdown
Clinical
27
Activity
18
Company
7
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06007183 | Phase 3 | Active |
Competing Products
20 competing products in Chikungunya Virus Infection